BioXcel Therapeutics, Inc. vs ABBOTT LABORATORIES, risk disclosures compared

4topics both disclose

4only BioXcel Therapeutics, Inc.

2only ABBOTT LABORATORIES

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	BioXcel Therapeutics, Inc.	ABBOTT LABORATORIES
Artificial Intelligence	48	1
Internal Control	12	3
Business Continuity	5	4
Material Weakness	1	1

Only BioXcel Therapeutics, Inc.

Topic	Filings
Enforcement Action	4
Privacy Compliance	3
Third Party Risk Management	3
Restatement	2

Only ABBOTT LABORATORIES

Topic	Filings
Consent Order	1
Data Breach	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

BioXcel Therapeutics, Inc. · ABBOTT LABORATORIES · All companies